Is segmentectomy potentially adequate for clinical stage IA3 non-small cell lung cancer
In well-selected patients with cIA3 NSCLC, segmentectomy leads to no statistical difference in oncologic outcomes compared to those observed in earlier stages in a relatively short follow-up period.
Authors
- Lin Huang (ORCID: https://orcid.org/0000-0002-6768-1141)
- Michel González (ORCID: https://orcid.org/0000-0001-8705-4279)
- René Horsleben Petersen (ORCID: https://orcid.org/0000-0002-3586-1869)
- Edoardo Zanfrini (ORCID: https://orcid.org/0000-0003-4158-7963)
- Alessandro Brunelli (ORCID: https://orcid.org/0000-0002-6505-1656)
- Abid Donlagic
- Demetrios Stefanous
Institutions
- St James's University Hospital (GB)
- Centre Hospitalier Universitaire Vaudois (CH)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
- University of Lausanne (CH)
Publication Details
- Journal
- Interdisciplinary CardioVascular and Thoracic Surgery
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1093/icvts/ivaf064
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Rigshospitalet